SmartAir

Asthma Prediction and Prevention Device

Health Tech & Life Sciences
Non Active, Mar 2018 ceased to operate

Company Overview

Snapshot

Founded in May 2016 by Uriel Klar, SmartAir operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on the development of its asthma prediction and prevention device.

Business overview

SmartAir develops a personal device designed to predict and prevent asthma attacks. The core technology involves collecting disease-related information and monitoring environmental triggers in real time. This enables the device to provide patients with real-time alerts about personal exposure risks, aiming to improve asthma management and reduce urgent healthcare costs. SmartAir operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Devices, leveraging artificial intelligence for its solutions.

Company Intelligence Q&A

What is SmartAir's primary focus?
SmartAir focuses on developing a personal device for predicting and preventing asthma attacks by monitoring disease-related information and environmental triggers in real time.
When was SmartAir founded?
SmartAir was founded in May 2016.
Who is the founder of SmartAir?
Uriel Klar is the founder of SmartAir.
What is SmartAir's current operational status?
SmartAir is currently non-active, having ceased operations in March 2018.
What technology does SmartAir utilize?
SmartAir utilizes artificial intelligence to collect and analyze disease-related information and environmental triggers for its asthma prediction and prevention device.